scholarly journals On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease

2021 ◽  
Vol 3 (4) ◽  
Author(s):  
Jana G Hashash ◽  
Francis A Farraye
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Vaccination Rates ◽  
Inflammatory Bowel

scholarly journals P353 Assessing compliance to screening for infectious diseases and vaccination in patients newly diagnosed with inflammatory bowel disease

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S336-S337
Author(s):  
R Pringle ◽  
A Assadsangabi
Keyword(s):  
Inflammatory Bowel Disease ◽  
Infectious Diseases ◽  
Bowel Disease ◽  
Clinic Visit ◽  
Varicella Zoster ◽  
Vaccination Rates ◽  
Vaccination History ◽  
Inflammatory Bowel ◽  
The Subject ◽  
The Uk

Abstract Background Patients are frequently counselled on vaccinations and screened for infectious diseases prior to starting immune-modulating therapy; however, the most up-to-date ECCO guideline on the subject (1) recommends vaccination screening and completion at diagnosis. We assessed adherence to the ECCO guidelines in patients diagnosed with inflammatory bowel disease (IBD). Methods Medical records from 100 IBD patients up to 6 months of their diagnosis were analysed retrospectively at a tertiary IBD centre in the UK. Data were collected for infectious diseases screening, documentation of vaccination history and education/advice on vaccination. Vaccination rates for diphtheria, tetanus, pertussis, polio, hepatitis B, human papillomavirus (HPV), influenza, pneumococcal and varicella-zoster were documented if they were recorded in the medical notes. Results A total of 84% of patients were not screened for infectious diseases at diagnosis or within 6 months. Overall, 97% had no vaccination history documented and 97% were not advised to attend their GPs for vaccinations. Conclusion Despite the existence of international guidelines, poor compliance to vaccination in patients with IBD has been shown in line with previous reports (2). This suboptimal vaccination compliance could be partly due to poor documentation and the retrospective method of data collection. However, there is clearly an urgent need for education and execution of vaccination guidelines in IBD. This implementation of work is now ongoing at our unit through automatic formal standard vaccination notification on every IBD clinic visit, which will be further re-audited in 6 months’ time.

549 IMPROVING VACCINATION RATES IN VETERANS WITH INFLAMMATORY BOWEL DISEASE (POSTER PRESENTATION)

2020 ◽  
Vol 158 (6) ◽  
pp. S-114
Author(s):  
Patrick Chen ◽  
Hyaehwan Kim ◽  
Jennifer Ball ◽  
Padmini Krishnamurthy
Keyword(s):  
Inflammatory Bowel Disease ◽  
Poster Presentation ◽  
Bowel Disease ◽  
Vaccination Rates ◽  
Inflammatory Bowel

scholarly journals Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan

Healthcare ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 6
Author(s):  
Yu Nishida ◽  
Shuhei Hosomi ◽  
Yumie Kobayashi ◽  
Rieko Nakata ◽  
Masaki Ominami ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Disease Duration ◽  
Vaccination Campaign ◽  
Vaccine Hesitancy ◽  
Multivariable Logistic Regression Analysis ◽  
Related Factors ◽  
Vaccination Rates ◽  
Inflammatory Bowel ◽  
Significant Factors

Coronavirus disease 2019 (COVID-19) vaccination is recommended for patients with inflammatory bowel disease (IBD). However, the acceptance of COVID-19 vaccines has not been sufficiently evaluated in patients with IBD. We aimed to assess the acceptance and hesitancy of COVID-19 vaccination and related factors among these patients. A retrospective cohort study using a self-reported questionnaire was performed among patients with IBD between 22 June 2021 and 30 August 2021. Of the 187 participants, 10.2% (n = 19) were hesitant to be vaccinated. Patients in the vaccine-hesitant group were younger (p = 0.009) and had a shorter disease duration (p = 0.020). Vedolizumab was prescribed more frequently (p = 0.024) and immunomodulators were less frequently used (p = 0.027) in this group. Multivariable logistic regression analysis identified age (odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.92–1.00, p = 0.042) and the use of immunomodulators (OR: 0.08, 95% CI: 0.01–0.66, p = 0.019) as independent significant factors for vaccine hesitancy. The COVID-19 vaccine hesitancy rate in patients with IBD in Japan was 10% in this study. The Japanese COVID-19 vaccination campaign appears to be successful. The risk of COVID-19 among patients with IBD requires adequate measures to ensure that vaccines are accepted by vaccine-hesitant patients. These findings may be helpful in achieving adequate vaccination rates.

P-049 Vaccination Rates in Inflammatory Bowel Disease

2013 ◽  
Vol 19 ◽  
pp. S46 ◽  
Author(s):  
Jason Abdallah ◽  
Kiran Anna ◽  
Tuyyab Hassan ◽  
Alok Jain
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Vaccination Rates ◽  
Inflammatory Bowel

scholarly journals P489 Are patients with inflammatory bowel disease receiving an adequate immunisation?

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S429-S430
Author(s):  
D Simian ◽  
P Núñez ◽  
L Flores ◽  
C Figueroa ◽  
P Ibáñez ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Influenza Vaccine ◽  
Bowel Disease ◽  
Cross Sectional ◽  
Live Virus ◽  
Vaccination Rates ◽  
Immunization Registry ◽  
Tertiary Centre ◽  
National Immunization ◽  
Inflammatory Bowel

Abstract Background Inflammatory Bowel Disease (IBD) treatment may increase the risk of infections. Vaccines are part of the comprehensive IBD patient care. The aim of this study was to describe indications and adherence of immunisations in IBD and identify possible associated factors. Methods A cross-sectional, analytic study was conducted in patients from an IBD Program of a tertiary centre in Chile, between April – June 2019. Demographic and clinical data were obtained from the hospital IBD registry, approved by the local IRB. Patients were asked to answer a vaccine survey and complementary information was obtained from the National Immunization Registry. Descriptive and association statistic were used (χ2; p <0.05). Results A total of 243 patients were included (Table 1). The influenza vaccine rate has significantly increased (Figure 1), reaching 67% in 2019, being higher in women (66% vs. 34%; p 0.045) and patients in biological therapy (BT) (29% vs. 14%; p 0.011) (Table 1). Vaccination rates are shown in Figure 2. Combination of Influenza/Hepatitis B/Pneumococcus vaccines was administered in 56 patients (23%), significantly higher in patients with BT and with fewer years of IBD. Forty patients received a live virus vaccine, 18% were on immunomodulatory treatment. The survey showed that 57 patients (23%) have not been immunised with any vaccine, mainly due to lack of time, lack of medical prescription and high cost. Conclusion In this cohort, vaccination rates are low, however, adherence to Influenza vaccine has increased. Immunisation should be considered early by the multidisciplinary team, educating patients about its importance.

Sign in / Sign up

Export Citation Format

Share Document